Skip to content

Nifedipine ointment in treatment of bedsore

Comparing efficacy of nifedipine ointment and placebo on healing of bedsore in critically ill patients: A clinical trial

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT201705073449N23
Enrollment
100
Registered
2017-06-04
Start date
2017-04-25
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bedsore. The ulcer appears as a defined area of persistent redness (erythema) in lightly pigmented skin, whereas in darker skin tones, the ulcer may appear with persistent red, blue or purple hues, without skin loss

Interventions

Intervention 1: Nifedipine 3% ointment (formulated in the faculty of pharmacy affiliated to Tehran University of Medical Sciences) twice daily topically cover all sores area for 14 days. Intervention
Treatment - Drugs
Placebo
Nifedipine 3% ointment (formulated in the faculty of pharmacy affiliated to Tehran University of Medical Sciences) twice daily topically cover all sores area for 14 days

Sponsors

Vice Chancellor for Research, Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria: Critically ill adult patients; with grade 1 or 2 of bedsore; hospitalized in Intensive Care Unit (ICU) for at-least 14 days; without history of nifedipine hypersensitivity reaction. Exclusion Criteria: Patients with severe bedsore requiring antibiotic therapy; worsening of bedsore during treatment course.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Grade of bedsore. Timepoint: At ICU admission and then day 14 of hospitalization. Method of measurement: 2-digit Stirling scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHossein Khalili

Tehran University of Medical Sciences

khalilih@tums.ac.ir+98 21 6695 4715

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026